BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Healthtrust
Citi
Daiichi Sankyo
UBS
Medtronic
Federal Trade Commission
Accenture
Moodys
US Army

Generated: January 23, 2018

DrugPatentWatch Database Preview

ALDOMET Drug Profile

« Back to Dashboard

When do Aldomet patents expire, and what generic alternatives are available?

Aldomet is a drug marketed by Merck and is included in three NDAs.

The generic ingredient in ALDOMET is methyldopa. There are nineteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the methyldopa profile page.

US Patents and Regulatory Information for ALDOMET

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck ALDOMET methyldopate hydrochloride INJECTABLE;INJECTION 013401-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Merck ALDOMET methyldopa TABLET;ORAL 013400-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Merck ALDOMET methyldopa SUSPENSION;ORAL 018389-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Merck ALDOMET methyldopa TABLET;ORAL 013400-003 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Merck ALDOMET methyldopa TABLET;ORAL 013400-002 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for ALDOMET

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck ALDOMET methyldopa SUSPENSION;ORAL 018389-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Healthtrust
Baxter
Covington
US Department of Justice
Colorcon
Express Scripts
Mallinckrodt
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot